Restructuring watch

Restructuring watch

DateCompanyStaff cutsCashYrs cash pre-cutCash date12-mo op loss ended 12/31
1/7/16Sequenom Inc. (NASDAQ:SQNM)20% to 390$76.29.6512/31/15$7.9
Sequenom restructured to focus on women's health and will look for commercialization partners for its cancer liquid biopsy assay. The company plans to sell its clinical genomic laboratory in Research Triangle Park, N.C., and consolidate those operations in San Diego, Calif. Sequenom expects the restructuring to save about $10M annually.
1/18/16iCo Therapeutics Inc. (TSX-V:ICO; OTCQX:ICOTF)100% to 0$2.42.221/18/16$0.8 (A)
iCo terminated all employees to preserve cash but has retained President and CEO

Read the full 833 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers